A controlled clinical trial with the cytostatic agent thyminalkylamine and its fluorinated derivative on advanced ovarian tumours.
D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008175:Lung Neoplasms / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013941:Thymine / Q000627:therapeutic use*
D000477:Alkylating Agents; D009588:Nitrogen Mustard Compounds; D005461:Fluorine; D013941:Thymine